Skip to main content
. 2023 Sep 9;11(17):e15639. doi: 10.14814/phy2.15639

TABLE 2.

Tilt test hemodynamic data of healthy controls and ME/CFS patients.

1 ME/CFS norm HRBP (n = 309) 2 ME/CFS POTS (n = 226) 3 HC norm BPHR (n = 34) p‐value one‐way ANOVA with Tukey's post hoc test
HR supine (bpm) 73 (11) 78 (12) 70 (11) F(2, 566) = 16.08, p < 0.0001; 1 vs. 2: p < 0.0001, 2 vs. 3: p = 0.0004
HR end‐tilt (bpm) 88 (12) 115 (17) 84 (14) F(2, 566) = 238.1, p < 0.0001; 1 vs. 2: p < 0.0001; 2 vs. 3: p < 0.0001
SBP supine (mmHg) 136 (18) 132 (16) 133 (16) F(2, 566) = 3.45, p = 0.03
SBP end‐tilt (mmHg) 134 (19) 126 (21) 125 (14) F(2, 566) = 11.74, p < 0.0001; 1 vs. 2: p < 0.0001
DBP supine (mmHg) 81 (12) 80 (10) 78 (7) F(2, 566) = 0.72, p = 0.49
DBP end‐tilt (mmHg) 88 (14) 87 (15) 81 (9) F(2, 566) = 3.84; p = 0.02
MAP supine (mmHg) 103 (13) 101 (12) 97 (9) F(2, 566) = 3.66, p = 0.03
MAP end‐tilt (mmHg) 106 (15) 104 (17) 95 (10) F(2, 566) = 7.84, p = 0.0004; 1 vs. 3: p = 0.0004
PETCO2 supine (mmHg) 37 (3) 36 (3) 37 (3) F(2, 566) = 3.53, p = 0.03
PETCO2 end‐tilt (mmHg) 30 (5) 26 (5) 36 (3) F(2, 566) = 61.80, p < 0.0001; 1 vs. 2: p < 0.0001; 1 vs. 3: p < 0.0001; 2 vs. 3: p < 0.0001
Delta CO2 end‐tilt min supine (mmHg) −7 (4) −10 (4) −2 (1) F(2, 566) = 65.44, p < 0.0001; 1 vs. 2: p < 0.0001; 1 vs. 3: p < 0.0001; 2 vs. 3: p < 0.0001
CBF supine (mL/min) 610 (101) 620 (98) 621 (82) F(2, 566) = 0.68, p = 0.51
CBF end‐tilt (mL/min) 442 (84) 429 (74) 577 (79) F(2, 566) = 51.01, p < 0.0001; 1 vs. 3: p < 0.0001; 2 vs. 3: p < 0.0001
%CBF end‐tilt—supine (mL/min) −28 (7) −31 (6) −7 (2) F(2, 566) = 197.4, p < 0.0001; 1 vs. 2: p < 0.0001; 1 vs. 3: p < 0.0001; 2 vs. 3: p < 0.0001

Abbreviations: CBF, cerebral blood flow; DBP, diastolic blood pressure; HC, healthy controls; HR, heart rate; MAP, mean arterial pressure; Norm HRBP, normal heart rate and blood pressure response during tilt test; PETCO2; end‐tidal carbon dioxide; POTS, postural orthostatic tachycardia syndrome during tilt test; SBP, systolic blood pressure.